Having received Diplomate status with the American Board of Internal Medicine and the American Board of Neurology and Psychiatry (N), Kenneth Gross, M.D. has always maintained a great interest in overlapping areas that include Internal Medicine, Psychiatry and of course Neurology.

He currently heads Fusion Clinical Multimedia, Inc., a medical education company in Miami, Florida, dedicated to areas that involve interspecialty issues. Dr. Gross has served as an instructor and consultant through Fusion at Nova Southeastern University at a psychopharmacology program for clinical psychologists and as a research neuroscientist at the Miami Project to Cure Paralysis. The interdisciplinary perspective is particularly germane to clinical decision making for the patient with Multiple Sclerosis.

Dr. Gross has delivered numerous Multiple Sclerosis lectures on this subject to health care professionals, patients, students and to pharmaceutical industry audiences. For him, MS is the "great neuroimmunological disease" that requires a merging of knowledge relevant to localization and phenomenology in Neurology and the immunopathogenesis of demyelinating syndromes.

Citing Dr. Labe Scheinberg, the late authority in MS as a key mentor during his training at the Albert Einstein College of Medicine, Dr. Gross carries with him a very healthy respect for the diversity of MS presentations. He agrees strongly with Scheinberg who said "If you've seen one patient with MS, you've seen one patient with MS".

Dr. Gross has recently collaborated in sharing educational program ideas with Dr. William Sheremata at the University of Miami who directs one of the nation's largest MS clinics. Like Gross, Sheremata frequently applies expertise in both Internal Medicine and Neurology in the evaluation of Multiple Sclerosis patients.

Expanding an interest in neuroimmunological and some neuro-infectious disease issues in Miami and in the Caribbean, Dr. Gross hopes to embark on additional clinical educational projects involving Cuba and Trinidad in the near future.